ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Overview Fund Activity
Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

26 hedge funds and large institutions have $3.67M invested in Oncternal Therapeutics, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
+2
Holders Change %
+8.33%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PPW
Pasadena Private Wealth
California
$190K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$116K
3
Morgan Stanley
Morgan Stanley
New York
$115K
4
Geode Capital Management
Geode Capital Management
Massachusetts
$197K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
$200K

Top Sellers

1
ACM
ADAR1 Capital Management
Texas
$0
2
QPW
Quantum Private Wealth
Florida
$204K
3
Millennium Management
Millennium Management
New York
$782K
4
Osaic Holdings
Osaic Holdings
Arizona
$1.14K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
$13K
Name Holding Trade Value Shares
Change 		Shares
Change %
NRG
26
Nemes Rush Group
Michigan
$23 – – –
ACM
27
ADAR1 Capital Management
Texas
– -$22.2K -2,472 Closed
TC
28
Truvestments Capital
Florida
– -$198 -22 Closed
1
2